These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6112274)

  • 21. Treatment of drug-induced agranulocytosis with recombinant GM-CSF.
    Palmblad J; Jonson B; Kanerud L
    J Intern Med; 1990 Nov; 228(5):537-9. PubMed ID: 1979344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Captopril-induced toxic epidermal necrolysis and agranulocytosis successfully treated with granulocyte colony-stimulating factor.
    Winfred RI; Nanda S; Horvath G; Elnicki M
    South Med J; 1999 Sep; 92(9):918-20. PubMed ID: 10498172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Granulocytopenia in treatment with salazopyrin].
    Kvarstein G; Hovdenak N
    Tidsskr Nor Laegeforen; 1988 Nov; 108(32):2982-3. PubMed ID: 2908084
    [No Abstract]   [Full Text] [Related]  

  • 24. Sulfasalazine associated agranulocytosis in Sweden 1972-1989. Clinical features, and estimation of its incidence.
    Keisu M; Ekman E
    Eur J Clin Pharmacol; 1992; 43(3):215-8. PubMed ID: 1358622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sulphasalazine-induced lupus syndrome in ulcerative colitis.
    Griffiths ID; Kane SP
    Br Med J; 1977 Nov; 2(6096):1188-9. PubMed ID: 22375
    [No Abstract]   [Full Text] [Related]  

  • 26. Sulphasalazine in ulcerative colitis.
    Drug Ther Bull; 1967 Nov; 5(24):93-4. PubMed ID: 4384228
    [No Abstract]   [Full Text] [Related]  

  • 27. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
    Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC;
    Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Desensitization for sulfasalazine skin rash.
    Purdy BH; Philips DM; Summers RW
    Ann Intern Med; 1984 Apr; 100(4):512-4. PubMed ID: 6142671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulphasalazine induced agranulocytosis.
    Hutchinson D; Wyld PJ
    N Z Med J; 1983 Jul; 96(735):520-1. PubMed ID: 6137796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory bowel disease, anaemia and sulphasalazine.
    Sheehan T; Tansey P; Cochran KM; O'Donnell JR
    Clin Lab Haematol; 1985; 7(3):275-8. PubMed ID: 2866864
    [No Abstract]   [Full Text] [Related]  

  • 32. Fibrosing alveolitis and treatment with sulphasalazine.
    Davies D; MacFarlane A
    Gut; 1974 Mar; 15(3):185-8. PubMed ID: 4152289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lyell's syndrome caused by Salazopyrine].
    Várkonyi V; Török I; Márta D; Makovitzky J
    Orv Hetil; 1976 Apr; 117(16):971-3. PubMed ID: 5694
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of ulcerative colitis with olsalazine and sulphasalazine: efficacy and side-effects.
    Ewe K; Eckardt V; Kanzler G
    Scand J Gastroenterol Suppl; 1988; 148():70-5. PubMed ID: 2906479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxic epidermal necrosis associated with mesalamine in a patient with ulcerative colitis.
    Fukunaga K; Ohda Y; Inoue T; Kono T; Miwa H; Matsumoto T
    Inflamm Bowel Dis; 2007 Aug; 13(8):1055-6. PubMed ID: 17309074
    [No Abstract]   [Full Text] [Related]  

  • 36. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study.
    Frey N; Bodmer M; Bircher A; Jick SS; Meier CR; Spoendlin J
    Drug Saf; 2019 Jan; 42(1):55-66. PubMed ID: 30112729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulphasalazine-induced systemic lupus erythematosus in a child.
    Vanheule BA; Carswell F
    Eur J Pediatr; 1983 Mar; 140(1):66-8. PubMed ID: 6135611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunologic mechanism in sulphasalazine-induced agranulocytosis.
    Victorino RM; Maria VA; de Deus J
    Acta Haematol; 1990; 84(2):111. PubMed ID: 1977273
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pathogenesis and treatment of toxic epidermal necrolysis].
    Hensen E
    Tijdschr Ziekenverpl; 1981 Jun; 34(13):563-7. PubMed ID: 6115482
    [No Abstract]   [Full Text] [Related]  

  • 40. Male infertility due to sulphasalazine therapy of ulcerous colitis.
    Ragni G; Bestetti O; Lombardi C; Wyssling H; Di Pietro R
    Acta Eur Fertil; 1983; 14(3):223-6. PubMed ID: 6142578
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.